Evidence map›Paper›PMID 36237627›Full record

ArticleFrontiers in neurology2022

Neuropsychiatric phenotype of post COVID-19 syndrome in non-hospitalized patients.

Julia Lier, Kristin Stoll, Hellmuth Obrig, Paul Baum, Lea Deterding, Nora Bernsdorff, Franz Hermsdorf, Ines Kunis, Andrea Bräsecke, Sabine Herzig and 7 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Julia LierDepartment of Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Kristin StollDepartment of Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Hellmuth ObrigMax-Planck-Institute of Human Cognitive and Brain Sciences & Clinic for Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Paul BaumDepartment for Cardiology, University of Leipzig Medical Center, Leipzig, Germany.
Lea DeterdingDepartment of Pneumology, University of Leipzig Medical Center, Leipzig, Germany.
Nora BernsdorffDepartment of Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Franz HermsdorfDepartment of Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Ines KunisDepartment of Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Andrea BräseckeDepartment of Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Sabine HerzigMax-Planck-Institute of Human Cognitive and Brain Sciences & Clinic for Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Matthias L SchroeterMax-Planck-Institute of Human Cognitive and Brain Sciences & Clinic for Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Angelika Thöne-OttoMax-Planck-Institute of Human Cognitive and Brain Sciences & Clinic for Cognitive Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Steffi G Riedel-HellerInstitute of Social Medicine, Occupational Health and Public Health, University of Leipzig Medical Center, Leipzig, Germany.
Ulrich LaufsDepartment for Cardiology, University of Leipzig Medical Center, Leipzig, Germany.
Hubert WirtzDepartment of Pneumology, University of Leipzig Medical Center, Leipzig, Germany.
Joseph ClassenDepartment of Neurology, University of Leipzig Medical Center, Leipzig, Germany.
Dorothee SaurDepartment of Neurology, University of Leipzig Medical Center, Leipzig, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The post COVID-19 syndrome (PCS) is an emerging phenomenon worldwide with enormous socioeconomic impact. While many patients describe neuropsychiatric deficits, the symptoms are yet to be assessed and defined systematically. In this prospective cohort study, we report on the results of a neuropsychiatric consultation implemented in May 2021. A cohort of 105 consecutive patients with merely mild acute course of disease was identified by its high symptom load 6 months post infection using a standardized neurocognitive and psychiatric-psychosomatic assessment. In this cohort, we found a strong correlation between higher scores in questionnaires for fatigue (MFI-20), somatization (PHQ15) and depression (PHQ9) and worse functional outcome as measured by the post COVID functional scale (PCFS). In contrast, neurocognitive scales correlated with age, but not with PCFS. Standard laboratory and cardiopulmonary biomarkers did not differ between the group of patients with predominant neuropsychiatric symptoms and a control group of neuropsychiatrically unaffected PCS patients. Our study delineates a phenotype of PCS dominated by symptoms of fatigue, somatisation and depression. The strong association of psychiatric and psychosomatic symptoms with the PCFS warrants a systematic evaluation of psychosocial side effects of the pandemic itself and psychiatric comorbidities on the long-term outcome of patients with SARS-CoV-2 infection.

Indexed as

COVID-19MFI-20neuropsychiatric disordersPCFSpost COVID-19 syndrome

Identifiers

PMID36237627
PMCPMC9552839

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.